23 results on '"Park, Hae‐Bin"'
Search Results
2. Immunosuppressive nanoparticles containing recombinant PD-L1 and methotrexate alleviate multi-organ inflammation
- Author
-
An, Eun-Koung, Zhang, Wei, Park, Hae-Bin, Kim, So-Jung, Eom, Hee-Yun, Hwang, Juyoung, Kwak, Minseok, Lee, Ji Yeon, Lee, Peter Chang-Whan, and Jin, Jun-O
- Published
- 2023
- Full Text
- View/download PDF
3. Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity
- Author
-
Hwang, Juyoung, An, Eun-Koung, Zhang, Wei, Park, Hae-Bin, Kim, So-Jung, Yadav, Dhananjay, Kim, Jihoe, Choi, Inho, Kwak, Minseok, Lee, Peter CW., Zhang, Xiaoyan, Xu, Jianqing, and Jin, Jun-O
- Published
- 2022
- Full Text
- View/download PDF
4. Comparison of the immune activation capacities of fucoidan and laminarin extracted from Laminaria japonica
- Author
-
An, Eun-Koung, Hwang, Juyoung, Kim, So-Jung, Park, Hae-Bin, Zhang, Wei, Ryu, Ja-Hyoung, You, SangGuan, and Jin, Jun-O
- Published
- 2022
- Full Text
- View/download PDF
5. Polysaccharide from Astragalus membranaceus promotes the activation of human peripheral blood and mouse spleen dendritic cells
- Author
-
Lim, Seong-Min, Park, Hae-Bin, and Jin, Jun-O
- Published
- 2021
- Full Text
- View/download PDF
6. Repeated intratracheal instillation of whole‐cigarette smoke condensate to assess lung damage in a rat model.
- Author
-
Kim, Jinhee, Cho, Yoon, Oh, Gi‐Jun, Park, Hae‐Bin, Yang, Mi Jin, Park, Chul‐Min, Kim, Yong‐Hyun, Choi, Kyung‐Chul, Go, Ryeo‐Eun, and Kim, Min‐Seok
- Subjects
LUNGS ,LUNG diseases ,CIGARETTE smoke ,SMOKING ,CHRONIC obstructive pulmonary disease ,ANIMAL disease models ,CHEMOKINE receptors - Abstract
Cigarette smoke induces an inflammatory response in the lungs by recruiting inflammatory cells, leading to lung diseases such as lung cancer, chronic obstructive pulmonary disease, and pulmonary fibrosis. Existing inhalation exposure methods for assessing the adverse effects of cigarette smoke require expensive equipment and are labor‐intensive. Therefore, we attempted to develop a novel method to assess these adverse effects using intratracheal instillation (ITI) of whole cigarette smoke condensate (WCSC). The WCSC (0, 5, 10, or 20 mg/mL) was administered by ITI once daily for 6 or 12 days using an automatic video instillator. Repeated WCSC ITI increased the lung weight, and monocyte chemoattractant protein‐1 (MCP‐1), neutrophil, and lymphocyte levels within bronchoalveolar lavage fluid compared to the control. In the histopathological analysis of the lung tissue, a mild inflammatory response was observed in the 6 and 12 days 20 mg/mL WCSC exposure groups. The genome‐wide RNA‐seq expression patterns revealed that inflammatory and immune response‐related genes, such as the chemokine signaling pathway, Th1/Th2 cell differentiation, and cytokine‐cytokine receptor interaction, were employed following WCSC exposure. In addition, MCP‐1 was time‐dependent and increased in the 10 mg/mL exposure group compared to the control group. These results suggested that the WCSC might induce the potential pulmonary inflammatory response. Furthermore, we proposed that ITI may be a rapid and effective method of evaluating the adverse effects of WCSC within a short exposure period (less than 2 weeks), and it can be used to evaluate cigarette inhalation toxicity studies as an alternative method. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Porphyran isolated from Pyropia yezoensis inhibits lipopolysaccharide-induced activation of dendritic cells in mice
- Author
-
Wang, Yuhua, Hwang, Ju-Young, Park, Hae-bin, Yadav, Dhananjay, Oda, Tatsuya, and Jin, Jun-O
- Published
- 2020
- Full Text
- View/download PDF
8. Annealing effect on electrochemical properties of patterned Si film electrodes for thin-film batteries
- Author
-
Jeong, Jae-Seung, Chae, Myung-Rang, Park, Hae-Bin, Im, Yeon-Min, Ahn, Hyo-Jun, Nam, Tae-Hyun, Kim, Ki-Won, and Cho, Gyu-Bong
- Published
- 2018
- Full Text
- View/download PDF
9. Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy
- Author
-
Zhang, Wei, Xu, Li, Park, Hae-Bin, Hwang, Juyoung, Kwak, Minseok, Lee, Peter C. W., Liang, Guang, Zhang, Xiaoyan, Xu, Jianqing, and Jin, Jun-O
- Published
- 2020
- Full Text
- View/download PDF
10. Artificial Immunogenic Cell Death Lipid Nanoparticle Functions as a Therapeutic Vaccine for Cancer.
- Author
-
Kim, So‐Jung, Park, Hae‐Bin, An, Eun‐Koung, Eom, Hee‐Yun, Zhang, Wei, Kim, Jihoe, Choi, Inho, Kwak, Minseok, Lee, Peter C. W., and Jin, Jun‐O
- Subjects
- *
CELL death , *ARTIFICIAL cells , *CANCER vaccines , *NANOPARTICLES , *CYTOTOXIC T cells , *NANOMEDICINE - Abstract
Anticancer drug‐mediated induction of immunogenic cell death (ICD) blocks metastasis or recurrence in cancer cells by promoting specific immune activity against cancer antigens. However, this strategy has failed to afford adequate treatment efficiency. Overcoming the failure of ICD‐mediated cancer therapy, lipid nanoparticles (LNPs) containing cancer cell surface proteins are synthesized using sonication and extrusion without microfluidics. In addition, these LNPs are decorated with high‐mobility group box 1 protein and calreticulin, indicators of ICD, and named artificial ICD LNPs (AiLNPs). Administration of AiLNPs effectively targets dendritic cells (DCs) and induces DC activation in mice. Moreover, treating CT‐26 tumor‐bearing mice with AiLNPs inhibits tumor growth by inducing CT‐26 antigen‐specific T‐cell immunity. Furthermore, AiLNPs containing Lewis lung carcinoma (LLC1) membrane proteins can prevent metastatic LLC1 tumor growth in the lung via LLC1 antigen‐specific T‐cell activation. Finally, AiLNPs synthesized with human breast cancer membrane proteins activate DC‐mediated antigen‐specific T‐cell immunity, effectively killing tumor cells. Therefore, AiLNPs are expected to be developed as a patient‐specific cancer treatment to prevent cancer recurrence and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Comparison of human peripheral blood dendritic cell activation by four fucoidans.
- Author
-
Zhang, Wei, Park, Hae-Bin, Yadav, Dhananjay, Hwang, Juyoung, An, Eun-Koung, Eom, Hee-Yun, Kim, So-Jung, Kwak, Minseok, Lee, Peter Chang-Whan, and Jin, Jun-O
- Subjects
- *
BLOOD cells , *GIANT kelp , *MAJOR histocompatibility complex , *FUCUS vesiculosus , *UNDARIA pinnatifida , *DENDRITIC cells - Abstract
Brown seaweed is an important source of fucoidan, which displays immunomodulatory effects by activating various immune cells. However, these effects of fucoidans from various sources of brown seaweed have not yet been explored in human blood dendritic cells. We studied fucoidans extracted from Ecklonia cava , Macrocystis pyrifera , Undaria pinnatifida , and Fucus vesiculosus for their effects on human monocyte-derived dendritic cells (MODC) and human peripheral blood DC (PBDC) activation. Ecklonia cava fucoidan (ECF) strongly upregulated co-stimulatory molecules, major histocompatibility complex class I and II, and the production of proinflammatory cytokines in MODCs and PBDCs compared to those by the other three fucoidans. Moreover, ECF elicited the strongest effect in the induction of syngeneic T cell proliferation and IFN-γ production compared to those of other fucoidans. These results suggest that ECF could be a suitable candidate molecule for enhancing immune activation in humans compared to that with the other three fucoidans. • ECF had higher fucose and uronic acid concentrations compared to MPF, UPF, and FVF. • ECF induced powerful human MODC and PBDC activation compared to other fucoidans. • ECF-stimulated DCs had stronger effect on syngeneic T cell proliferation and IFN-γ production than other fucoidans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Dendritic cell-mediated cancer immunotherapy with Ecklonia cava fucoidan.
- Author
-
Park, Hae-Bin, Hwang, Juyoung, Lim, Seong-Min, Zhang, Wei, and Jin, Jun-O
- Subjects
- *
GREEN'S functions , *DENDRITIC cells , *T cells , *IMMUNOTHERAPY , *TUMOR growth , *TUMOR antigens , *CD25 antigen - Abstract
Fucoidan is known to exert immunomodulatory effects in animals and humans. Here, we extracted fucoidan from Ecklonia cava (ECF) and evaluated its immunostimulatory and anticancer activities in mice. Treatment with ECF resulted in the activation of bone marrow-derived dendritic cells (BMDCs) in vitro and splenic DCs in vivo. Moreover, the combination of ECF and ovalbumin (OVA) promoted OVA-specific T cell proliferation and cytokine production, which consequently suppressed B16-OVA tumor growth in vivo. The combination treatment with ECF and carcinoma self-antigen resulted in the inhibition of the growth of CT-26 carcinoma in mice through carcinoma antigen-specific immunity. Thus, ECF could function as an adjuvant for the induction of anticancer immunity. • ECF induces activation of mouse DCs in vitro and in vivo. • ECF promotes antigen-specific T cell immunity in mouse in vivo. • Combination treatment of ECF and cancer antigen suppresses tumor growth in mouse. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Cancer immunotherapy using a polysaccharide from Codium fragile in a murine model.
- Author
-
Park, Hae-Bin, Lim, Seong-Min, Hwang, Juyoung, Zhang, Wei, You, SangGuan, and Jin, Jun-O
- Subjects
- *
CYTOTOXIC T cells , *KILLER cells , *ADJUVANT treatment of cancer , *DENDRITIC cells , *TUMOR necrosis factors ,BONE marrow cancer - Abstract
Natural polysaccharides have shown immune modulatory effects with low toxicity in both animal and human models. A previous study has shown that the polysaccharide from Codium fragile (CFP) promotes natural killer (NK) cell activation in mice. Since NK cell activation is mediated by dendritic cells (DCs), we examined the effect of CFP on DC activation and evaluated the subsequent induction of anti-cancer immunity in a murine model. Treatment with CFP induced activation of bone marrow-derived dendritic cells (BMDCs). Moreover, subcutaneous injection of CFP promoted the activation of spleen and lymph node DCs in vivo. CFP also induced activation of DCs in tumor-bearing mice, and combination treatment with CFP and ovalbumin (OVA) promoted OVA-specific T cell activation, which consequently promoted infiltration of IFN-γ-and TNF-α-producing OT-1 and OT-II cells into the tumors. Moreover, combination treatment using CFP and cancer self-antigen efficiently inhibited B16 tumor growth in the mouse model. Treatment with CFP also enhanced anti-PD-L1 antibody mediated anti-cancer immunity in the CT-26 carcinoma-bearing BALB/c mice. Taken together these data suggest that CFP may function as an adjuvant in the treatment of cancer by enhancing immune activation. CFP: Codium fragile polysaccharide; NK: natural killer; IFN: interferon; TNF: tumor necrosis factor; IL: interleukin; tdLN: tumor draining lymph node; BMDC: bone marrow-derived dendritic cell; OVA: ovalbumin; Ab: antibody; Ag: antigen; DC: dendritic cell; CTL: cytotoxic T lymphocyte; APC: antigen-presenting cell; pDC: plasmacytoid dendritic cell; mDC: myeloid dendritic cell; MHC: major histocompatibility complex; CR3: complement receptor type 3; TLR: Toll-like receptor; LPS: lipopolysaccharide; SP: sulfated polysaccharide; TRP2: tyrosinase-related protein 2; SR-A: scavenger receptor-A [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. Pyropia yezoensis-derived porphyran attenuates acute and chronic colitis by suppressing dendritic cells.
- Author
-
Park, Hae-Bin, Kim, So-Jung, Yadav, Dhananjay, An, Eun-Koung, Zhang, Wei, Eom, Hee-Yun, Kwak, Minseok, Oda, Tatsuya, Lee, Peter Chang-Whan, and Jin, Jun-O
- Subjects
- *
COLITIS , *ORAL drug administration , *T helper cells , *MACROPHAGE activation , *DEXTRAN sulfate - Abstract
Porphyran is known to inhibit immune cell function. Previously, porphyran was shown to prevent lipopolysaccharide-induced sepsis in mice. However, studies on the inhibitory effects of porphyran during colitis are currently lacking. In this study, we evaluated the effects of Pyropia yezoensis- derived porphyran on dextran sodium sulfate (DSS)-induced acute and chronic colitis. The oral or intraperitoneal administration of porphyran inhibited the progression of DSS-induced colitis in mice, with the former also preventing immune cell infiltration in the colon. The levels of intracellular interferon-γ and interleukin-17 in T cells decreased when porphyran was administered orally. Porphyran inhibited T cell activation by suppressing dendritic cells (DCs) and macrophages. Porphyran prevented pathogen-associated molecular pattern and damage-associated molecular pattern-dependent DC and macrophage activation. Finally, porphyran attenuated chronic colitis caused via the long-term administration of DSS. These findings indicate that the oral administration of porphyran can inhibit DSS-induced colitis by suppressing DC and macrophage activation. • Porphyran administered orally alleviated DSS-induced murine colitis. • Porphyran prevented immune cell infiltration during DSS-induced colitis. • Porphyran inhibited DAMP and PAMP-dependent activation of DCs. • DSS-induced chronic inflammation in the colon was inhibited by porphyrin. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Polysaccharide from Codium fragile Induces Anti-Cancer Immunity by Activating Natural Killer Cells.
- Author
-
Park, Hae-Bin, Hwang, Juyoung, Zhang, Wei, Go, Seulgi, Kim, Jihoe, Choi, Inho, You, SangGuan, and Jin, Jun-O
- Abstract
Natural polysaccharides exhibit beneficial immune modulatory effects, including immune stimulatory and anti-cancer activities. In this study, we examined the effect of Codium fragile polysaccharide (CFP) on natural killer (NK) cell activation, and its effect on tumor-bearing mice. Intravenous CFP treatment of C57BL/6 mice resulted in the upregulation of CD69, which is a marker associated with NK cell activation. In addition, intracellular levels of interferon (IFN)-γ and the cytotoxic mediators perforin and granzyme B were markedly increased in response to the CFP treatment of splenic NK cells. IFN-γ production by NK cells was directly induced by CFP, whereas the upregulation of CD69 and cytotoxic mediators required IL-12. Finally, intraperitoneal treatment with CFP prevented CT-26 (murine carcinoma) tumor cell infiltration in the lungs, without significantly reducing the body weight. In addition, treatment with CFP prevented B16 melanoma cell infiltration in the lung of C57BL/6 mice. Moreover, the anti-tumor effect was diminished by the depletion of NK cells. Therefore, these data suggest that CFP may be used as an NK cell stimulator to produce a phenomenon that contributes to anti-cancer immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
16. Human Peripheral Blood Dendritic Cell and T Cell Activation by Codium fragile Polysaccharide.
- Author
-
Zhang, Wei, Hwang, Juyoung, Park, Hae-Bin, Lim, Seong-Min, Go, Seulgi, Kim, Jihoe, Choi, Inho, You, Sangguan, and Jin, Jun-O
- Abstract
Natural polysaccharides exhibit an immunostimulatory effect with low toxicity in humans and animals. It has shown that polysaccharide extracted from Codium fragile (CFP) induces anti-cancer immunity by dendritic cell (DC) activation, while the effect of CFP has not examined in the human immune cells. In this study, we found that CFP promoted the upregulation of CD80, CD83 and CD86 and major histocompatibility complex (MHC) class I and II in human monocyte-derived dendritic cells (MDDCs). In addition, CFP induced the production of proinflammatory cytokines in MDDCs. Moreover, CFP directly induced the activation of Blood Dendritic Cell Antigen (BDCA)1
+ and BDCA3+ subsets of human peripheral blood DCs (PBDCs). The CFP-stimulated BDCA1+ PBDCs further promoted activation and proliferation of syngeneic CD4 T cells. The CFP-activated BDCA3+ PBDCs activated syngeneic CD8 T cells, which produced cytotoxic mediators, namely, cytotoxic T lymphocytes. These results suggest that CFP may be a candidate molecule for enhancing immune activation in humans. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
17. Alumina Ceramic Exacerbates the Inflammatory Disease by Activation of Macrophages and T Cells.
- Author
-
Lim, Seong-Min, Hwang, Juyoung, Park, Hae-Bin, Park, Chan Ho, and Jin, Jun-O
- Subjects
T cells ,MACROPHAGE activation ,ARTIFICIAL joints ,DEXTRAN sulfate ,CERAMICS ,PERITONEAL macrophages ,TOOTH abrasion - Abstract
(1) Background: Aluminum oxide (Al
2 O3 ) ceramic is one of the materials used for artificial joints, and it has been known that their fine particles (FPs) are provided by the wear of the ceramic. Al2 O3 FPs have been shown to induce macrophage activation in vitro; however, the inflammatory effect in vivo has not been studied. (2) Methods: We examined the in vivo effect of Al2 O3 FPs on the innate and adaptive immune cells in the mice. (3) Results: Al2 O3 FPs promoted the activation of spleen macrophages; however, conventional dendritic cells (cDCs), plasmacytoid DCs (pDCs), and natural killer (NK) cells were not activated. In addition, increases in the CD4 and CD8 T cells was induced in the spleens of the mice treated with Al2 O3 FPs, which differentiated into interferon-gamma (IFN-γ)-producing helper T1 (Th1) and cytotoxic T1 (Tc1) cells. Finally, the injection of Al2 O3 FPs exacerbated dextran sulfate sodium (DSS)-induced inflammation in the colon, mediated by activated and increased number of CD4 and CD8 T cells. (4) Conclusions: These data demonstrate that FPs of Al2 O3 ceramic may contribute to the exacerbation of inflammatory diseases in the patients. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. Ecklonia cava fucoidan has potential to stimulate natural killer cells in vivo.
- Author
-
Zhang, Wei, An, Eun-Koung, Park, Hae-Bin, Hwang, Juyoung, Dhananjay, Yadav, Kim, So-Jung, Eom, Hee-Yun, Oda, Tatsuya, Kwak, Minseok, Lee, Peter Chang-Whan, and Jin, Jun-O
- Subjects
- *
KILLER cells , *LUNGS , *ASCOPHYLLUM nodosum , *GIANT kelp , *FUCUS vesiculosus , *UNDARIA pinnatifida , *LAMINARIA - Abstract
Fucoidan is a sulfated polysaccharide, derived from various marine brown seaweeds, that has immunomodulatory effects. In this study, we analyzed the effects of five different fucoidans, which were extracted from Ascophyllum nodosum , Undaria pinnatifida , Macrocystis pyrifera , Fucus vesiculosus , and Ecklonia cava , on natural killer (NK) cell activation in mice. Among these, E. cava fucoidan (ECF) promoted an increase in the number of NK cells in the spleen and had the strongest effect on the activation of NK cells. Additionally, we observed that DC stimulation was required for NK cell activation and that ECF had the most potent effect on splenic dendritic cells (DC). Finally, ECF treatment effectively prevented infiltration of CT-26 carcinoma cells in the lungs of BALB/c mice in an NK cell dependent manner. Collectively, these results suggest that ECF could be a suitable candidate for enhancing NK cell-mediated anti-cancer immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Indocyanine green and poly I:C containing thermo-responsive liposomes used in immune-photothermal therapy prevent cancer growth and metastasis.
- Author
-
Xu, Li, Zhang, Wei, Park, Hae-Bin, Kwak, Minseok, Oh, Junghwan, Lee, Peter C. W., and Jin, Jun-O
- Subjects
METASTASIS ,INDOCYANINE green ,TUMOR growth ,LIPOSOMES ,CANCER treatment ,LIPOTEICHOIC acid - Abstract
Background: Efficient cancer therapy is sought not only for primary tumor treatment but also for the prevention of metastatic cancer growth. Immunotherapy has been shown to prevent cancer metastasis by inducing antigen-specific immune responses. Indocyanine green (ICG) has a peak spectral absorption at about 800 nm, which makes it a photothermal reagent for direct treatment of solid tumors by photothermal therapy (PTT). Since PTT alone cannot fully induce antigen-specific immune response for prevention of cancer metastasis, the combination of PTT and immunotherapy has been developed as a new strategy of cancer treatment. Methods: Thermal responsive liposomes (TRL) were synthesized by incorporating ICG into the lipid bilayer and encapsulating the water-soluble immune stimulatory molecule polyinosinic:polycytidylic acid (poly I:C) in the hydrophilic core. The poly I:C- and ICG-containing TRLs (piTRLs) were analyzed according to size, and their photothermal effect was evaluated following laser irradiation at 808 nm. Moreover, the temperature-dependent release of poly I:C was also measured. For cancer therapy, CT-26 (carcinoma) and B16 (melanoma) cells were subcutaneously inoculated to build the 1st transplanted tumor in BALB/c and C57BL/6 mice, respectively. These mice received a 2nd transplantation with the same cancer cells by intravenous inoculation, for evaluation of the anti-metastatic effects of the liposomes after PTT. Results: Near-infrared (NIR) laser irradiation increased the temperature of piTRLs and effectively released poly I:C from the liposomes. The increased temperature induced a photothermal effect, which promoted cancer cell apoptosis and dissolution of the 1st transplanted tumor. Moreover, the released poly I:C from the piTRL induced activation of dendritic cells (DCs) in tumor draining lymph node (tdLN). Cancer cell apoptosis and DC-activation-mediated cancer antigen-specific immune responses further prevented growth of lung metastatic cancer developed following intravenous transplantation of cancer cells. Conclusion: These results demonstrated the potential usage of a piTRL with laser irradiation for immuno-photothermal therapy against various types of cancer and their metastases. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
20. Activation of Human Dendritic Cells by Ascophyllan Purified from Ascophyllum nodosum.
- Author
-
Zhang, Wei, Kwak, Minseok, Park, Hae-Bin, Okimura, Takasi, Oda, Tatsuya, Lee, Peter Chang-Whan, and Jin, Jun-O
- Abstract
In our previous study, we showed that ascophyllan purified from Ascophyllum nodosum treatment promotes mouse dendritic cell (DC) activation in vivo, further induces an antigen-specific immune response and has anticancer effects in mice. However, the effect of ascophyllan has not been studied in human immune cells, specifically in terms of activation of human monocyte-derived DCs (MDDCs) and human peripheral blood DCs (PBDCs). We found that the treatment with ascophyllan induced morphological changes in MDDCs and upregulated co-stimulatory molecules and major histocompatibility complex class I (MHC I) and MHC II expression. In addition, pro-inflammatory cytokine levels in culture medium was also dramatically increased following ascophyllan treatment of MDDCs. Moreover, ascophyllan promoted phosphorylation of ERK, p38 and JNK signaling pathways, and inhibition of p38 almost completely suppressed the ascophyllan-induced activation of MDDCs. Finally, treatment with ascophyllan induced activation of BDCA1 and BDCA3 PBDCs. Thus, these data suggest that ascophyllan could be used as an immune stimulator in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. Drosophila melanogaster as potential alternative animal model for evaluating acute inhalation toxicity.
- Author
-
Cho Y, Park CM, Heo YJ, Park HB, and Kim MS
- Subjects
- Animals, Models, Animal, Drosophila melanogaster genetics, Inhalation Exposure adverse effects, Thiazoles
- Abstract
Drosophila melanogaster (D. melanogaster) is a promising model biological system. It has a short life cycle and can provide a substantial number of specimens suitable for comprehensive genetic and molecular analyses in a short time. In this study, we investigated the acute inhalation toxicity of methylisothiazolinone (MIT) and chloromethylisothiazolinone (CMIT) in a D. melanogaster model. During exposure, environmental conditions, mass median aerodynamic and geometric standard diameters were measured. After inhalation exposure, the survival rate, climbing ability, and bang sensitivity were measured on days 1, 2, and 7. Notably, the survival rate of flies decreased in an exposure concentration-dependent manner. Climbing ability and bang sensitivity were also altered in the MIT/CMIT group, compared with the negative control group. Overall, these results provide a reliable D. melanogaster model system for inhalation toxicity study.
- Published
- 2024
- Full Text
- View/download PDF
22. Escherichia coli adhesion protein FimH exacerbates colitis via CD11b + CD103 - dendritic cell activation.
- Author
-
Zhang W, An EK, Kim SJ, Park HB, Lee PCW, and Jin JO
- Subjects
- Animals, Humans, Mice, Inflammation metabolism, Mice, Inbred C57BL, Colitis, Dendritic Cells
- Abstract
Introduction: Immune stimulators are used to improve vaccine efficiency; however, they are accompanied by various side effects. In previous studies, we reported that the Escherichia coli adhesion protein, FimH, induces immune activity; however, we did not examine any side effects in colon inflammation., Methods: FimH was administered orally or intraperitoneally ( i.p. ) to mice with dextran sulfate sodium (DSS)-induced colitis, and changes in symptoms were observed. Immune cells infiltrated into the colon after the induction of colon inflammation were analyzed using a flow cytometer. Changes in Th1 and Th17 cells that induce colitis were analyzed. Further, mesenteric lymph node (mLN) dendritic cells (DCs) activated by FimH were identified and isolated to examine their ability to induce T-cell immunity., Results: FimH oral and i.p. administration in C57BL/6 mice did not induce inflammation in the colon; however, DSS-induced colitis was exacerbated by oral and i.p. FimH administration. FimH treatment increased immune cell infiltration in the colon compared to that in DSS colitis. Th1 and Th17 cells, which are directly related to colitis, were increased in the colon by FimH; however, FimH did not directly affect the differentiation of these T cells. FimH upregulated the CD11b
+ CD103- DC activity in the mLNs, which produced the signature cytokines required for Th1 and Th17. In addition, isolated CD11b+ CD103- DCs, after stimulation with FimH, directly induced Th1 and Th17 differentiation in a co-culture of CD4 T cells., Conclusion: This study demonstrated the side effects of FimH and indicated that the use of FimH can aggravate the disease in patients with colitis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Zhang, An, Kim, Park, Lee and Jin.)- Published
- 2023
- Full Text
- View/download PDF
23. Escherichia coli adhesin protein-conjugated thermal responsive hybrid nanoparticles for photothermal and immunotherapy against cancer and its metastasis.
- Author
-
Hwang J, Zhang W, Park HB, Yadav D, Jeon YH, and Jin JO
- Subjects
- Animals, Cell Line, Tumor, Female, Humans, Mice, Neoplasm Metastasis, Adhesins, Escherichia coli therapeutic use, Immunotherapy methods, Nanoparticles therapeutic use, Neoplasms therapy, Photothermal Therapy methods
- Abstract
Background: Advanced cancer therapy is targeted at primary tumors and also recurrent or metastatic cancers. Combinational cancer treatment has recently shown high efficiency against recurrent and metastatic cancers. In this study, we synthesized a thermal responsive hybrid nanoparticle (TRH) containing FimH, an immune stimulatory recombinant protein, for the induction of a combination of photothermal therapy (PTT) and immunotherapy against cancer and its metastasis., Methods: The hybrid nanoparticle was incorporated with a near-infrared (NIR) absorbent, indocyanine green, and decorated with FimH on its surface to form F-TRH. F-TRH was evaluated for its anticancer and antimetastatic effects against CT-26 carcinoma in mice by combining PTT and immunotherapy., Results: NIR laser irradiation elicited an elevation of temperature in F-TRH, which induced apoptosis in CT-26 carcinoma cells in vitro. In addition, F-TRH and NIR laser irradiation promoted photothermal-mediated therapeutic effects against CT-26 and 4T1 tumors in mice. The release of FimH from F-TRH in response to elevated temperature and apoptotic bodies of cancer cells via PTT elicited dendritic cell-mediated cancer antigen-specific T-cell responses, which subsequently inhibited the second challenge of CT-26 and 4T1 cell growth in the lung., Conclusions: These data demonstrate the potential use of F-TRH for immuno-photothermal therapy against cancer and its recurrence and metastasis., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.